TY - JOUR
T1 - Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies
T2 - Evidence for autoimmunity including neurologic and connective tissue diseases
AU - Davis, John M.
AU - Moder, Kevin G.
AU - Homburger, Henry A.
AU - Ytterberg, Steven R.
PY - 2005/7/1
Y1 - 2005/7/1
N2 - Systemic lupus erythematosus (SLE) rarely presents with a negative antinuclear antibody (ANA). Although antibodies to extractable nuclear antigens (ENA) are sometimes ordered despite a negative ANA, it is unclear if this contributes to the diagnosis of SLE or other forms of connective tissue disease (CTD). We reviewed 39 patients with anti-ENA antibodies despite a negative ANA during a 1-year period to determine the presence of SLE or other CTD. Several patients had clinical features suggestive of CTD, including 1 with possible SLE. A number of patients had neurologic disorders, especially peripheral neuropathy. In this study, the finding of anti-ENA despite negative ANA was associated with neurologic disorders and CTD. This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described.
AB - Systemic lupus erythematosus (SLE) rarely presents with a negative antinuclear antibody (ANA). Although antibodies to extractable nuclear antigens (ENA) are sometimes ordered despite a negative ANA, it is unclear if this contributes to the diagnosis of SLE or other forms of connective tissue disease (CTD). We reviewed 39 patients with anti-ENA antibodies despite a negative ANA during a 1-year period to determine the presence of SLE or other CTD. Several patients had clinical features suggestive of CTD, including 1 with possible SLE. A number of patients had neurologic disorders, especially peripheral neuropathy. In this study, the finding of anti-ENA despite negative ANA was associated with neurologic disorders and CTD. This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described.
UR - http://www.scopus.com/inward/record.url?scp=22644443029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=22644443029&partnerID=8YFLogxK
U2 - 10.1097/01.md.0000173181.87969.eb
DO - 10.1097/01.md.0000173181.87969.eb
M3 - Article
C2 - 16010205
AN - SCOPUS:22644443029
SN - 0025-7974
VL - 84
SP - 208
EP - 217
JO - Medicine
JF - Medicine
IS - 4
ER -